| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9155091 | American Heart Journal | 2005 | 8 Pages |
Abstract
In high-risk patients with NSTE ACS, strong consideration should be given to initiation of therapy with aspirin, enoxaparin, a GP IIb/IIIa inhibitor, and clopidogrel while pursuing an early invasive approach.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shaun MD, MSc,